Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the “Commission”)** LICENSE AGREEMENTLicense Agreement • May 1st, 2017 • Therapix Biosciences Ltd. • Pharmaceutical preparations
This Research and License Agreement (“Agreement”) is made in Jerusalem this 30th day of March 2017 (the “Effective Date”), by and between:
